by | Jul 21, 2022 | Cohen, Barak, Zhao, Siqi
— Technology Description
Researchers in Barak Cohen’s lab at Washington University have developed a method for single cell massively parallel reporter assay (scMPRA) to preserve cell type-specific information. This technology is scalable and sequencing platform agnostic.
Massively parallel…
by | Jul 21, 2022 | Cohen, Barak, Zhao, Siqi
— Technology Description
Researchers in Barak Cohen’s lab at Washington University have developed a method for single cell massively parallel reporter assay (scMPRA) to preserve cell type-specific information. This technology is scalable and sequencing platform agnostic.
Massively parallel…
by | Mar 10, 2022 | Kremer, Jeff, Lange, Sara, Van Tine, Brian
— Background: Synovial sarcoma is a rare soft tissue sarcoma that most commonly affects young adults. Like many other cancers, there are currently no targeted chemotherapies for synovial sarcoma. Current treatment often consists of a combination of surgery, radiation therapy, and chemotherapy. The met…
by | Mar 10, 2022 | Kremer, Jeff, Lange, Sara, Van Tine, Brian
— Background: Synovial sarcoma is a rare soft tissue sarcoma that most commonly affects young adults. Like many other cancers, there are currently no targeted chemotherapies for synovial sarcoma. Current treatment often consists of a combination of surgery, radiation therapy, and chemotherapy. The met…
by | Jan 25, 2022 | Bowman, Gregory
— Technology Description
Researchers in Greg Bowman’s lab at Washington University have developed an improved method for rational drug and protein design called Boltzmann docking. This process better incorporates the dynamic structures of proteins to identify sites for binding that are not rev…